sgn-75
mAbexperimentalADC
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2009 (NCT01015911)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- CD70 antigenINHIBITOR
CD70 inhibitor
Chemistry & pharmacology
- Multi-specific
- No
- Payload
- Monomethylauristatin F
Oral
No
Parenteral
No
Topical
No
Also known as
- sgn-75
- sgn-75
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01677390 | Phase 1 | Aug 1, 2012 | Seattle Genetics |
| NCT01015911 | Phase 1 | Nov 1, 2009 | Seattle Genetics |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Seattle Genetics | For profit | 2 | 2 | 1 | 2009 |
1 organizations
Page 1 / 1